The ETA–ESE statement on the European Chemicals Agency opinion on iodine as an endocrine disruptor
In 2022, the European Chemicals Agency (ECHA) made a statement concluding that iodine is an endocrine disruptor (ED). We stress the fact that the ECHA opinion ECHA/BPC/357/2022 is based on their misguidedly zooming in on exclusively the biocidal products (e.g. hand disinfectants, disinfection of ani...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2024-02-01
|
| Series: | European Thyroid Journal |
| Subjects: | |
| Online Access: | https://etj.bioscientifica.com/view/journals/etj/13/1/ETJ-23-0244.xml |
| _version_ | 1827572914402099200 |
|---|---|
| author | Rodrigo Moreno-Reyes Ulla Feldt-Rasmussen Agnieszka Piekiełko-Witkowska Adriana Gaspar da Rocha Corin Badiu Josef Köhrle Leonidas Duntas |
| author_facet | Rodrigo Moreno-Reyes Ulla Feldt-Rasmussen Agnieszka Piekiełko-Witkowska Adriana Gaspar da Rocha Corin Badiu Josef Köhrle Leonidas Duntas |
| author_sort | Rodrigo Moreno-Reyes |
| collection | DOAJ |
| description | In 2022, the European Chemicals Agency (ECHA) made a statement concluding that iodine is an endocrine disruptor (ED). We stress the fact that the ECHA opinion ECHA/BPC/357/2022 is based on their misguidedly zooming in on exclusively the biocidal products (e.g. hand disinfectants, disinfection of animals’ teats/udder, embalming fluids before cremation) that contain molecular iodine (I2), entirely neglecting the 2013 ECHA Regulation (EU) no. 528/2012 describing iodine as being of ‘great importance for human health’. Clearly, the current sweeping and erroneous classification of ‘iodine’ as an endocrine disruptor is ill-advised. We moreover call upon the scientific and medical community at large to use the accurate scientific nomenclature, i.e. iodide or iodate instead of ‘iodine’ when referring to iodized salts and food prepared there with. Drugs, diagnostic agents, and synthetic chemicals containing the element iodine in the form of covalent bonds must be correctly labeled ‘iodinated’, if possible, using each time their distinctive and accurate chemical or pharmacological name. |
| first_indexed | 2024-03-07T19:59:34Z |
| format | Article |
| id | doaj.art-f43f9cf473704c629d22af9f293b301c |
| institution | Directory Open Access Journal |
| issn | 2235-0802 |
| language | English |
| last_indexed | 2024-03-07T19:59:34Z |
| publishDate | 2024-02-01 |
| publisher | Bioscientifica |
| record_format | Article |
| series | European Thyroid Journal |
| spelling | doaj.art-f43f9cf473704c629d22af9f293b301c2024-02-28T11:20:56ZengBioscientificaEuropean Thyroid Journal2235-08022024-02-0113116https://doi.org/10.1530/ETJ-23-0244The ETA–ESE statement on the European Chemicals Agency opinion on iodine as an endocrine disruptorRodrigo Moreno-Reyes0Ulla Feldt-Rasmussen1Agnieszka Piekiełko-Witkowska2Adriana Gaspar da Rocha3Corin Badiu4Josef Köhrle5Leonidas Duntas6Department of Nuclear Medicine, Hospital Erasme, Université Libre de Bruxelles, Brussels, BelgiumDepartment of Endocrinology and Metabolism, University Hospital Rigshospitalet, and Faculty of Ηealth and Clinical Sciences, University of Copenhagen, Copenhagen, DenmarkCentre of Postgraduate Medical Education, Centre of Translational Research, Department of Biochemistry and Molecular Biology, Warsaw, Poland: Basic Lead of the European Society of Endocrinology Focus Area on ThyroidPublic Health Unit, ULS Baixo Mondego, Figueira da Foz, Portugal Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal Health Investigation and Innovation Institute (i3S), University of Porto, Porto, PortugalNational Institute of Endocrinology "C. Davila" University of Medicine and Pharmacy, Bucharest, RomaniaCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Berlin, Germany: Co-Lead of the European Society of Endocrinology Focus Area on Environmental EndocrinologyEvgenideion Hospital, Unit of Endocrinology, Metabolism and Diabetes, National Kapodistrian University of Athens, Athens, GreeceIn 2022, the European Chemicals Agency (ECHA) made a statement concluding that iodine is an endocrine disruptor (ED). We stress the fact that the ECHA opinion ECHA/BPC/357/2022 is based on their misguidedly zooming in on exclusively the biocidal products (e.g. hand disinfectants, disinfection of animals’ teats/udder, embalming fluids before cremation) that contain molecular iodine (I2), entirely neglecting the 2013 ECHA Regulation (EU) no. 528/2012 describing iodine as being of ‘great importance for human health’. Clearly, the current sweeping and erroneous classification of ‘iodine’ as an endocrine disruptor is ill-advised. We moreover call upon the scientific and medical community at large to use the accurate scientific nomenclature, i.e. iodide or iodate instead of ‘iodine’ when referring to iodized salts and food prepared there with. Drugs, diagnostic agents, and synthetic chemicals containing the element iodine in the form of covalent bonds must be correctly labeled ‘iodinated’, if possible, using each time their distinctive and accurate chemical or pharmacological name.https://etj.bioscientifica.com/view/journals/etj/13/1/ETJ-23-0244.xmleta-eseiodine statementiodineecha |
| spellingShingle | Rodrigo Moreno-Reyes Ulla Feldt-Rasmussen Agnieszka Piekiełko-Witkowska Adriana Gaspar da Rocha Corin Badiu Josef Köhrle Leonidas Duntas The ETA–ESE statement on the European Chemicals Agency opinion on iodine as an endocrine disruptor European Thyroid Journal eta-ese iodine statement iodine echa |
| title | The ETA–ESE statement on the European Chemicals Agency opinion on iodine as an endocrine disruptor |
| title_full | The ETA–ESE statement on the European Chemicals Agency opinion on iodine as an endocrine disruptor |
| title_fullStr | The ETA–ESE statement on the European Chemicals Agency opinion on iodine as an endocrine disruptor |
| title_full_unstemmed | The ETA–ESE statement on the European Chemicals Agency opinion on iodine as an endocrine disruptor |
| title_short | The ETA–ESE statement on the European Chemicals Agency opinion on iodine as an endocrine disruptor |
| title_sort | eta ese statement on the european chemicals agency opinion on iodine as an endocrine disruptor |
| topic | eta-ese iodine statement iodine echa |
| url | https://etj.bioscientifica.com/view/journals/etj/13/1/ETJ-23-0244.xml |
| work_keys_str_mv | AT rodrigomorenoreyes theetaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT ullafeldtrasmussen theetaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT agnieszkapiekiełkowitkowska theetaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT adrianagaspardarocha theetaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT corinbadiu theetaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT josefkohrle theetaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT leonidasduntas theetaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT rodrigomorenoreyes etaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT ullafeldtrasmussen etaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT agnieszkapiekiełkowitkowska etaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT adrianagaspardarocha etaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT corinbadiu etaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT josefkohrle etaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor AT leonidasduntas etaesestatementontheeuropeanchemicalsagencyopiniononiodineasanendocrinedisruptor |